...and how much lab staff time is devoted to overseeing these tests and
training the staff?
Who looks after and pays for EQA?
Did you discuss your TaT with A&E before embarking on this, or did they want
to do this anyway, irrespective of any service improvements you could
introduce?
Were your procedures for protocol driven requesting agreed locally?
Dr Richard Taylor
Clinical Biochemist
Dept of Clinical Biochemistry
John Radcliffe Hospital
Oxford
> ----------
> From: Jonathan Kay
> Reply To: ACB Point of Care Testing List
> Sent: Tuesday, April 22, 2003 19:20 PM
> To: [log in to unmask]
> Subject: Re: POCT in casualty departments
>
> That's probably the most ambitious plan I've heard of in the UK. Can I
> push you a bit further...
>
> What is your current model for in-laboratory analysis... do they need
> to 'phone? 24 x7? Air tubes? Guaranteed TaT? What medium do you use to
> return the reports?
>
> What were seen as the major benefits... did anyone think you'd get
> faster patient throughput? ( I think you won't but the clinical staff
> will find there is less hassle than in-laboratory analysis
>
> Do the time windows for patients stay in ED (national target) and for
> troponin to be informative overlap in many patients?
>
> Are you worried about training EDAs on so many platforms?
>
> Jonathan
>
>
>
> On Tuesday, Apr 22, 2003, at 17:20 Europe/London, Paul Eldridge wrote:
>
> > The jury is out at present at Lewisham. The trust is very keen to
> > implement a system but put the project on hold at the last minute
> > because of the revenue cost.
> > I estimated the revenue cost in terms of POCT "reagents" was estimated
> > as approximately £100K above current expenditure. The tests will be
> > done by Emergency Department Assistants (EDAs) already in post dealing
> > with phlebotomy, cannulation and ECGs following nurse triage and
> > protocol driven test requests with results available before seeing the
> > Drs.
> > This is for FBC on a Pentra60, U&E plus glucose on Istat (£40K),
> > Troponin I on Dade Behring Stratus (£30K), CRPs and D Dimers, INRs
> > linked via a PGP interface to the lab Telepath computer with output to
> > the hospital database.
> > LFTs, amylase, and other tests will be sent by air-tube to the lab but
> > samples will be booked in and barcoded by the EDAs.
> > We are exploring alternative strategies at present.
> >
> > Dr Paul H Eldridge
> > Clinical Biochemist
> > University Hospital Lewisham
> > London SE13 6LH
> > UK
> > Phone: (44) 020 8333 3255
> > Fax: (44) 020 8690 8891
> >
> >
> >
> > [log in to unmask]
> >
> > **********************************************************************
> > DISCLAIMER:
> >
> > Any opinions expressed in this email are those of the individual and
> > not necessarily the Trust. This email and any files transmitted with
> > it are confidential and intended solely for the use of the individual
> > or entity to whom they are addressed. Any unauthorised disclosure of
> > the information contained in this e-mail is strictly prohibited.
> >
> > The contents of this email may contain software viruses which could
> > damage your own computer system. Whilst we have taken every
> > reasonable precaution to minimise this risk, we cannot accept liability
> > for any damage which you sustain as a result of software viruses.
> > You should therefore carry out your own virus checks before opening
> > the attachment.
> >
> > If you have received this email in error please notify the sender or
> > [log in to unmask] Please then delete this email.
> >
> > University Hospital Lewisham
> > Tel: 020 8333 3000
> > Web: http://www.lewisham.nhs.uk/
> > **********************************************************************
>
>
|